Literature DB >> 1439189

Serum and organ indices of the mdx dystrophic mouse.

G A Brazeau1, M Mathew, R K Entrikin.   

Abstract

Duchenne muscular dystrophy (DMD) is a fatal disease for which there is no effective treatment. The cause of death in patients with DMD is often cardiovascular and pulmonary dysfunction. This clinical observation, combined with experimental findings, suggests that other non-muscle organ systems may be affected in the dystrophic disease state. To test this hypothesis, the present study investigated liver and kidney function in the mdx mouse. Serum chemistries and the hepatic cytochrome P-450 system in normal and dystrophic mdx mice were investigated at two different ages. Increases in serum lactate dehydrogenase (LDH), alkaline phosphatase (AP), aspartate transaminase (AST), and cholesterol levels, combined with an increase in liver weight and a decrease in cytochrome P-450, suggests the possibility of hepatic dysfunction. Increases in serum uric acid and phosphorus, and decreased kidney weight suggest hepatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439189

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  8 in total

1.  MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Natássia M Vieira; Iris Eisenberg; Jamie L Marshall; Molly J Gasperini; Angela Lek; Jennifer A Myers; Elicia A Estrella; Peter B Kang; Frederic Shapiro; Fedik Rahimov; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

2.  Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse.

Authors:  Eiji Wada; Takayuki Hamano; Isao Matsui; Mizuko Yoshida; Yukiko K Hayashi; Ryoichi Matsuda
Journal:  J Physiol Sci       Date:  2019-05-11       Impact factor: 2.781

3.  Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.

Authors:  Refik Kayali; Jin-Mo Ku; Gregory Khitrov; Michael E Jung; Olga Prikhodko; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2012-06-12       Impact factor: 6.150

4.  DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.

Authors:  Andrea L Reid; Yimin Wang; Adrienne Samani; Rylie M Hightower; Michael A Lopez; Shawn R Gilbert; Lara Ianov; David K Crossman; Louis J Dell'Italia; Douglas P Millay; Thomas van Groen; Ganesh V Halade; Matthew S Alexander
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

5.  Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice.

Authors:  Gang Han; Ben Gu; Limin Cao; Xianjun Gao; Qingsong Wang; Yiqi Seow; Ning Zhang; Matthew J A Wood; HaiFang Yin
Journal:  Nat Commun       Date:  2016-03-11       Impact factor: 14.919

6.  Long-Term Morpholino Oligomers in Hexose Elicits Long-Lasting Therapeutic Improvements in mdx Mice.

Authors:  Gang Han; Caorui Lin; Hanhan Ning; Xianjun Gao; HaiFang Yin
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-21       Impact factor: 8.886

7.  Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.

Authors:  Anna M L Coenen-Stass; Graham McClorey; Raquel Manzano; Corinne A Betts; Alison Blain; Amer F Saleh; Michael J Gait; Hanns Lochmüller; Matthew J A Wood; Thomas C Roberts
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

8.  Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.

Authors:  HaiFang Yin; Hong M Moulton; Yiqi Seow; Corinne Boyd; Jordan Boutilier; Patrick Iverson; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2008-09-10       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.